Michael Griffin
Stock Analyst at Citigroup
(2.96)
# 1,321
Out of 4,667 analysts
12
Total ratings
100%
Success rate
28.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $28.35 | -50.62% | 1 | Mar 4, 2024 | |
| JLL Jones Lang LaSalle | Maintains: Neutral | $178 | $258.92 | -31.25% | 3 | Sep 18, 2023 | |
| CBRE CBRE Group | Maintains: Buy | $98 | $131.65 | -25.56% | 4 | Sep 18, 2023 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $17.80 | -4.49% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $3.05 | +47.54% | 2 | May 19, 2023 |
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $28.35
Upside: -50.62%
Jones Lang LaSalle
Sep 18, 2023
Maintains: Neutral
Price Target: $178
Current: $258.92
Upside: -31.25%
CBRE Group
Sep 18, 2023
Maintains: Buy
Price Target: $98
Current: $131.65
Upside: -25.56%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $17.80
Upside: -4.49%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $3.05
Upside: +47.54%